Market Research Logo

Sirnaomics, Inc. - Product Pipeline Review - 2016

Sirnaomics, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Sirnaomics, Inc. - Product Pipeline Review - 2016’, provides an overview of the Sirnaomics, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sirnaomics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Sirnaomics, Inc.
The report provides overview of Sirnaomics, Inc. including its business description, key facts, and locations and subsidiaries
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report assesses Sirnaomics, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
The report features Sirnaomics, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Sirnaomics, Inc.’s strategic position with total access to detailed information on its product pipeline
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of therapeutics under development for Sirnaomics, Inc.
Identify potential new clients or partners in the target demographic
Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Sirnaomics, Inc.’s pipeline depth and focus of pipeline therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Table of Contents
List of Tables
List of Figures
Sirnaomics, Inc. Snapshot
Sirnaomics, Inc. Overview
Key Information
Key Facts
Sirnaomics, Inc. - Research and Development Overview
Key Therapeutic Areas
Sirnaomics, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Sirnaomics, Inc. - Pipeline Products Glance
Sirnaomics, Inc. - Early Stage Pipeline Products
IND/CTA Filed Products/Combination Treatment Modalities
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Sirnaomics, Inc. - Drug Profiles
STP-705
Product Description
Mechanism of Action
R&D Progress
STP-302
Product Description
Mechanism of Action
R&D Progress
STP-503
Product Description
Mechanism of Action
R&D Progress
STP-523
Product Description
Mechanism of Action
R&D Progress
STP-601
Product Description
Mechanism of Action
R&D Progress
STP-702
Product Description
Mechanism of Action
R&D Progress
STP-801
Product Description
Mechanism of Action
R&D Progress
STP-900
Product Description
Mechanism of Action
R&D Progress
STP-902
Product Description
Mechanism of Action
R&D Progress
STP-909
Product Description
Mechanism of Action
R&D Progress
STP-703
Product Description
Mechanism of Action
R&D Progress
STP-805
Product Description
Mechanism of Action
R&D Progress
STP-911
Product Description
Mechanism of Action
R&D Progress
STP-916
Product Description
Mechanism of Action
R&D Progress
Sirnaomics, Inc. - Pipeline Analysis
Sirnaomics, Inc. - Pipeline Products by Target
Sirnaomics, Inc. - Pipeline Products by Route of Administration
Sirnaomics, Inc. - Pipeline Products by Molecule Type
Sirnaomics, Inc. - Pipeline Products by Mechanism of Action
Sirnaomics, Inc. - Recent Pipeline Updates
Sirnaomics, Inc. - Dormant Projects
Sirnaomics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Sirnaomics, Inc., Key Information
Sirnaomics, Inc., Key Facts
Sirnaomics, Inc. - Pipeline by Indication, 2016
Sirnaomics, Inc. - Pipeline by Stage of Development, 2016
Sirnaomics, Inc. - Monotherapy Products in Pipeline, 2016
Sirnaomics, Inc. - IND/CTA Filed, 2016
Sirnaomics, Inc. - Preclinical, 2016
Sirnaomics, Inc. - Discovery, 2016
Sirnaomics, Inc. - Pipeline by Target, 2016
Sirnaomics, Inc. - Pipeline by Route of Administration, 2016
Sirnaomics, Inc. - Pipeline by Molecule Type, 2016
Sirnaomics, Inc. - Pipeline Products by Mechanism of Action, 2016
Sirnaomics, Inc. - Recent Pipeline Updates, 2016
Sirnaomics, Inc. - Dormant Developmental Projects,2016
Sirnaomics, Inc., Subsidiaries
List of Figures
Sirnaomics, Inc. - Pipeline by Top 10 Indication, 2016
Sirnaomics, Inc. - Pipeline by Stage of Development, 2016
Sirnaomics, Inc. - Monotherapy Products in Pipeline, 2016
Sirnaomics, Inc. - Pipeline by Target, 2016
Sirnaomics, Inc. - Pipeline by Route of Administration, 2016
Sirnaomics, Inc. - Pipeline by Molecule Type, 2016
Sirnaomics, Inc. - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report